Cherry angiomas are benign growths of tiny blood vessels in the skin, and accumulating dozens or even hundreds of them is far more common than most people realize. In a large population-based study, the median count was 12 to 16 per person, and roughly a quarter of participants had 30 or more. They are overwhelmingly harmless, and “too many” is a threshold that shifts depending on who is counting. That said, a sudden eruption of many new angiomas in a short window can occasionally signal a medication reaction, a chemical exposure, or, rarely, an underlying disease worth investigating.
What Counts as a Normal Number
Most adults over 30 have at least a few cherry angiomas, and counts climb steadily with age. A study that mapped cherry angiomas across a general population found that men had a median of 16 and women a median of 12, with individual totals ranging from zero to nearly 300. About 60 percent of participants had more than 10 angiomas larger than one millimeter, which meets at least one published definition of “eruptive” cherry angiomas. Using a stricter cutoff of 50 or more, roughly one in six people still qualified. When only angiomas larger than two millimeters were counted, the numbers dropped but remained substantial.
The point is that there is no universally agreed-upon number that separates normal from abnormal. Different researchers have used thresholds of 10, 30, and 50 to define “eruptive” cherry angiomas, and each cutoff captures a very different slice of the population.
Why They Appear and Keep Appearing
Cherry angiomas are made up of clusters of small, thin-walled blood vessels lined by a single layer of cells, often surrounded by a distinctive pinkish material visible under the microscope. They are essentially tiny, benign vascular tumors, and their formation is driven by somatic mutations that accumulate in skin cells over a lifetime.
Researchers using genetic sequencing on cherry angioma tissue have found that about half of the samples carry activating mutations in genes called GNAQ and GNA11. These are the same families of genes mutated in other vascular growths and even some cancers like uveal melanoma, but in cherry angiomas the mutations appear to drive only the local, limited overgrowth of blood vessels in the skin. A larger study of 85 cases found that mutations in a related gene, GNA14, were the most common, confirming that cherry angiomas belong to a broader family of vascular growths sharing overlapping genetic drivers.
Because these are somatic mutations (arising in individual skin cells rather than inherited), they accumulate with age, which is why cherry angiomas become more numerous as you get older. Your skin essentially rolls the genetic dice billions of times over the years, and occasionally a cell picks up one of these activating mutations and starts building a tiny new cluster of blood vessels.
Who Gets More of Them
Age is the single strongest predictor, but it is not the only one. A multivariate analysis found that being male, having fair skin, being of Caucasian ancestry, and having green or hazel eye color were all independently associated with higher cherry angioma counts. Interestingly, a personal history of melanoma was also linked to having more cherry angiomas, though the study did not establish a causal relationship in either direction.
The sex difference is modest but consistent: men tend to have more angiomas than women at every age. Whether this reflects hormonal influences, differences in sun exposure patterns, or something else entirely is not settled. The association with lighter skin tones and eye color hints at a possible connection to skin pigmentation pathways, though the mechanism is unclear.
When a Sudden Crop of New Ones Deserves Attention
The gradual accumulation of cherry angiomas over years is routine. What raises eyebrows is the sudden appearance of many new ones over weeks or months, a pattern called eruptive cherry angiomatosis. The underlying cause is often unknown, but case reports and small studies have linked this pattern to several triggers.
Medications are the best-documented trigger. Case reports have connected eruptive angiomas to drugs including cyclosporine, ramucirumab, and other immunosuppressive or targeted therapies. One report described patients using the inhaled bronchodilator ipratropium bromide who developed unusually large, violaceous angiomas in sun-exposed areas, with notable sparing of covered skin. The researchers proposed a photo-induced drug eruption and coined the term “bromangiomas” for the presentation. In both patients the angiomas appeared in areas getting the most sun while areas under a watchband or clothing stayed clear.
Chemical exposures have also been implicated. A case study documented six workers who developed eruptive cherry angiomas on their arms, trunks, and thighs within four months of a single acute overexposure to the industrial solvent 2-butoxyethanol. The workers were understandably alarmed, suspecting cancer, but the angiomas turned out to be the benign vascular growths typical of cherry angiomas, simply triggered earlier and in greater numbers than would normally be expected. Separately, long-term topical application of nitrogen mustard for vitiligo treatment was reported to cause cherry angiomas to erupt within and around treated skin. Stopping the nitrogen mustard halted the appearance of new lesions.
A broader review of the literature notes that eruptive cherry angiomas have also been associated with lymphoproliferative diseases, graft-versus-host disease, immunosuppression, and human herpesvirus-8 infection. These associations are drawn from case reports and small series, so their frequency is hard to estimate, but they underscore why a sudden burst of new angiomas is worth mentioning to a doctor even though the growths themselves are benign.
The Old Cancer Connection
The worry that cherry angiomas signal internal cancer has a surprisingly long history. The surgeon Campbell de Morgan first described these lesions in his 1872 book On the Origin of Cancer, noting that they appeared frequently in patients with malignancies. For decades they were sometimes called “de Morgan spots,” and other nineteenth-century physicians, including Leser and Trélat, similarly believed that a large number of cherry angiomas, especially in younger adults, pointed to hidden cancers.
Modern evidence has largely put this idea to rest for the ordinary, gradually accumulating type. Cherry angiomas are so common in the general population that their presence alone carries essentially no diagnostic value for malignancy. However, the eruptive pattern described above has been linked in case reports to lymphoproliferative diseases and immunosuppression, so the nineteenth-century intuition was not entirely wrong. It was just far too broad. The distinction that matters today is not how many you have but how fast they appeared and whether they came with other symptoms.
The Lipid Connection
One observation that surfaces in the literature is a possible link between cherry angiomas and blood lipid levels. A case-control study found that people with cherry angiomas had higher average levels of total cholesterol, LDL cholesterol, and triglycerides compared to controls, with statistically significant differences for all three. HDL cholesterol was also slightly higher in the angioma group, but that difference did not reach statistical significance.
This does not mean cherry angiomas are caused by high cholesterol. The study was observational and relatively small, so it cannot establish causation. It is possible that both cherry angiomas and lipid abnormalities are independently driven by aging and metabolic changes, or there may be a shared vascular pathway. Some researchers have speculated that lipid metabolism affects the endothelial cells lining small blood vessels in ways that promote angioma formation, but this remains speculative. Still, if you have a large number of cherry angiomas and have not had your cholesterol checked in a while, it might be worth doing so for general cardiovascular health rather than because the angiomas themselves are dangerous.
How to Tell a Cherry Angioma from Something Else
Cherry angiomas are usually easy to recognize: small, round, bright red to dark red bumps that do not change shape or bleed spontaneously. Under dermoscopy, they show characteristic reddish-brown to reddish-blue lacunae (small pools of blood) and may display serpentine, coiled, or looped blood vessels. A few can appear darker or develop a faint whitish surface, which can complicate visual diagnosis, but these features vary predictably by body location and patient age.
The lesions that cause the most confusion are amelanotic melanomas (melanomas that lack the typical dark pigmentation), pyogenic granulomas (rapidly growing vascular lumps that tend to bleed easily), and angiokeratomas (similar-looking vascular spots with a rougher, slightly scaly surface). Dermoscopy helps distinguish among these: pyogenic granulomas and cherry angiomas can both show a red to reddish-white structureless zone, but pyogenic granulomas tend to grow quickly, bleed with minor trauma, and often have an irregular shape.
The practical takeaway is that a single cherry angioma that looks or behaves differently from the rest of your collection is the one to get checked. A spot that is growing rapidly, bleeding without being scratched, has an irregular border, or is much darker than your other angiomas deserves a professional look. A collection of 50 identical-looking red dots that arrived gradually over the last decade almost certainly does not.
Removal Options If They Bother You
Cherry angiomas do not require treatment for medical reasons. Most people who seek removal do so for cosmetic reasons or because an angioma is in a spot that gets snagged by clothing or jewelry.
The two most commonly studied in-office approaches are electrosurgery (using a fine electrical current to destroy the blood vessels) and cryotherapy (freezing with liquid nitrogen). A randomized clinical trial comparing the two found that both patients and physicians rated satisfaction significantly higher with electrosurgery for cherry angiomas. Cryotherapy carries a slightly higher risk of hypopigmentation and depigmentation at the treatment site, which can be particularly noticeable on darker skin tones. Electrosurgery can occasionally leave a small atrophic scar, but overall it appears to be the preferred method for these growths.
Pulsed dye laser and intense pulsed light are also used in dermatology offices, and many practitioners consider laser treatment the gold standard for larger or more numerous angiomas because it targets the hemoglobin inside the blood vessels while causing minimal damage to surrounding skin. Shave excision, where a doctor slices the angioma off flush with the skin surface, is another quick option, particularly if a pathology sample is wanted to confirm the diagnosis.
For most people the decision is purely cosmetic. If you have a few that are annoying, electrosurgery or laser is quick and straightforward. If you have hundreds, treating them all may not be practical, and new ones will continue to appear over time regardless of how many you remove.
What Cherry Angiomas Share with Other Vascular Growths
The genetic mutations found in cherry angiomas are not unique to them. The same GNAQ and GNA11 mutations show up in port-wine stains, congenital hemangiomas, blue nevi, and even some vascular tumors of the liver. This overlap suggests that many vascular growths across different tissues arise from the same signaling pathway being switched on at the wrong time or in the wrong place. The difference in clinical outcome, whether you get a harmless red dot on your chest or a more complex vascular lesion, likely depends on when during development the mutation occurs, which cell type acquires it, and what surrounding tissue signals are present.
This shared molecular background is one reason researchers have paid increasing attention to cherry angiomas in recent years. They are among the most accessible and common examples of this mutational pathway at work, making them a convenient window into how vascular overgrowth gets started. For the person wondering why they keep finding new red dots on their torso, the practical relevance is limited, but it does explain why cherry angiomas are not just random blemishes. They are small, contained examples of a well-characterized genetic event, one that happens to be essentially harmless in this particular form.